| Revenue growth | 78.48% YoY growth in FY26 revenue. |
|---|---|
| Margins | EBITDA margin 37.5%; expansion driven by in-house lamination and packaging. |
| Order book | ₹137cr intact; 25% of South African 1B piece tender expected. |
| Demand visibility | Strong; South Africa 1B piece annual tender; global female condom shortage. |
| Management confidence | High; citing niche product status and patented in-house machinery. |
Growth
FY26 revenue ₹137.42cr (+78.48% YoY). H2FY26 revenue ₹83.32cr (+82.77% YoY). Net profit ₹34.30cr (+107% YoY).
Outlook
Guidance to reach ₹1,000cr revenue within 2 years. Capacity expansion to 806M male condoms and 240M female condoms.
Risks
Government payment realization cycles (120+ days); raw material (latex) price volatility during monsoon seasons.
Earnings Call filed with NSE, NSE: ANONDITA. Summary written with AI assistance from the document.
Anondita Medicare Limited: key numbers
- Share price
- ₹1,150.25
- Market cap
- ₹2,191 Cr
- Revenue (annual)
- ₹137.4 Cr
- Net profit (annual)
- ₹33.45 Cr
- P/E (TTM)
- 65.5×Sector 43.4×
- Promoter holding
- 62.40%
- FII holding
- 3.40%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Anondita Medicare Limited
All →Anondita Medicare Capital Structure Change
Anondita Medicare Limited has reinstated its previous rights issue corrigendum. The issue size is now confirmed at 9,58,166 equity shares, aggregating to ₹91.03 Crore.
- Value
- ₹91.03 Cr
Anondita Medicare Capital Structure Change
Anondita Medicare Limited issued a corrigendum to its Rights Issue, revising the total issue size to ₹91.03 Crore and adjusting the allocation for general corporate purposes.
- Value
- ₹91.03 Cr
Anondita Medicare Other Announcement
Anondita Medicare Limited clarified procedures for handling odd lots of Rights Entitlements and shares during its ongoing Rights Issue. No new transaction value is involved.
Anondita Medicare Annual General Meeting
Anondita Medicare Limited has issued the notice for its 3rd Annual General Meeting scheduled for September 29, 2026. The meeting will address ordinary and special business resolutions.
Anondita Medicare H1 FY26 Results: Net Profit ₹13 Cr, Up 116.7% YoY
Anondita Medicare Ltd reported revenue from operations of ₹54.1 Cr (+72.3% YoY) and net profit of ₹13 Cr (+116.7% YoY) for H1 FY26.
- Key figure
- Net profit ₹13 Cr · +116.7% YoY
Anondita Medicare Earnings Call: Key Takeaways
Anondita Medicare Limited (ANONDITA) reports FY26 revenue of ₹13,741.57 Cr with 37.5% EBITDA margins. The company is scaling capacity and expanding internationally across Brazil and South Africa.
- Call
- Guides 65% growth